Stratagene California

Stratagene California is an American biotechnological company based in La Jolla, California,[1] a maker of life science research and diagnostic products.[2] It was established in 1984 and incorporated in California.[3] It has been involved with the fields of cellular analysis, cloning, cytogenomics, DNA methylation and DNA Sizing and Quantification[1] and food testing. In 2007, Agilent Technologies acquired Stratagene for $250 million,[4] spinning off certain business assets and licensing certain molecular diagnostics technology to a new entity, Decisive Diagnostics.[5][2] As of October 2011, the Chief Executive of the new company is Joseph Sorge, original founder and CEO of Stratagene.[6]

References
  1. Ahuja, M. R.; Boerjan, Wout; Neale, David B., eds. (1996). Somatic cell genetics and molecular genetics of trees. Springer. p. 198. ISBN 978-0-7923-4179-6. Retrieved 19 October 2011.
  2. "Agilent Technologies Completes Stratagene Acquisition; Raises Q3 Revenue Outlook - Update". RTTNews. Retrieved 2020-07-14.
  3. "Stratagene California". Manta.com. Retrieved 19 October 2011.
  4. "Agilent Announce Definitive Agreement to Acquire Stratagene for $250 Million". Genomics Research from Technology Networks. Retrieved 2020-07-14.
  5. "Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene". Agilent press release. Retrieved 28 December 2016.
  6. "Joseph Sorge M.D." Bloomberg Businessweek. Retrieved 19 October 2011.

Further reading
  • Kraul, Chris (5 June 1987). "2 From Stratagene Win Entrepreneur of the Year Award". Los Angeles Times.
  • Dalton, Rex (11 May 1990). "Firms' battle over 'silver bullet' technology opens in federal court". San Diego Union Tribune.
  • Dalton, Rex (11 July 1991). "Biotech company plans partial move". San Diego Union Tribune.
  • Somers, Terri (3 June 2004). "Stratagene acquires Hycor, goes public". San Diego Union Tribune.
  • Gores, Paul (20 December 2005). "Judge triples damages in Third Wave case; $15.9 million awarded for patent infringement". Milwaukee Journal Sentinel.
  • Somers, Terri (21 March 2006). "Innovation paying off: Profitable San Diego biotech tool company finds success in niche market". San Diego Union Tribune.
  • Somers, Terri (7 April 2007). "La Jolla-based biotech bought for $245 million". San Diego Union Tribune.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.